期刊文献+

GP73的研究进展 被引量:15

暂未订购
导出
摘要 高尔基体糖蛋白-73(Golgi Protein73,GP73)又称Ⅱ型高尔基体膜蛋白(Golgi phosphoprotein 2,GOLPH2)和GOLM1,因其在SDS-PAGE中显示相对分子质量为7.3×104,所以称为GP73[1]。近期研究表明。
出处 《肝胆外科杂志》 2011年第1期70-72,共3页 Journal of Hepatobiliary Surgery
  • 相关文献

参考文献6

  • 1Riener MO,,Stenner F,Liewen H,et al.Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology . 2009
  • 2Li X,Wu K,Fan D.Serum Golgi Phosphoprotein 2 level:a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Hepatology . 2009
  • 3Riener MO,,Stenner F,Liewen H,et al.Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology . 2009
  • 4Puri S,Bachert C,Fimmel CJ,et al.Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pHdisruption. Traf-fic . 2002
  • 5Bachert C,Fimmel C,Linstedt AD.Endosomal trafficking and prop-rotein convertase cleavage of cis Golgi protein GP73produces marker for hepatocellular carcinoma. Traffic . 2007
  • 6毛一雷,杨华瑜,徐海峰,桑新亭,卢欣,杨志英,张锦春,钟守先,黄洁夫,张宏冰.新的肝癌血清标记物GP73在肝癌诊断中的初步研究[J].中华医学杂志,2008,88(14):948-951. 被引量:132

二级参考文献5

  • 1Cassandra Willyard. Researchers look for ‘sweet' method to diagnose cancer. Nat Med, 2007, 13: 1267.
  • 2Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgilocalized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
  • 3Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35 : 1431-1440.
  • 4Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
  • 5徐海峰,杨华瑜,张宏冰,毛一雷.改变肝癌早期诊断和治疗现状的新肝癌血清标志物[J].基础医学与临床,2008,28(1):104-108. 被引量:118

共引文献131

同被引文献133

  • 1张雯,钱金雄,肖彦革,陈缵光.甲胎蛋白异质体(AFP-L3)检测技术的研究进展[J].分子诊断与治疗杂志,2009,1(3):213-216. 被引量:9
  • 2Lin Zhou,Jia Liu,Feng Luo.Serum tumor markers for detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(8):1175-1181. 被引量:79
  • 3Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis,2010,30( 1 ) :3 - 16.
  • 4Feher J, Lengyel G. Hepatocellular carcinoma : occurrence, risk fac- tors, biomarkers. Orv Hetil,2010,151 (23) :933 - 940.
  • 5Bruix J, Sherman M. Management of hepatocellular carcinoma. Hep- atology ,2005,42 ( 5 ) : 1208 - 1236.
  • 6Wang M, Long RE, Comunale MA, et al. Novel fucosylated biomar- kers for the early detection of hepatocellular carcinoma. Cancer Epi- demiol Biomarkers Prev, 2009, 18 (6) :1914 -1921.
  • 7Mao Y, Yang H, Xu 17, et al. Golgi protein 73 (GOLPH2) is a val- uable serum marker for hepatocellular carcinoma. Gut, 2010, 59 (12) :1687 - 1693.
  • 8Shi Y, Chert J, Li L, A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma. Technol Cancer Res Treat, 2011,10 ( 3 ) : 287 - 294.
  • 9Zhou Y, Yin X, Ying J, et al. Golgi protein 73 versus alpha-fetopro- rein as a biomarker for hepatocellular carcinoma: a diagnostic meta-a- nalysis. BMC Cancer, 2012,16 ; 12 : 17.
  • 10Kladney RD, Bulla GA, Guo L,et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene,2000,249( 1 -2) :53 - 65.

引证文献15

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部